From April 1, 2022 to June 30, 2022, the company has repurchased 79,620 shares, representing 0.03% for CNY 4.86 million. With this, the company has completed the repurchase of 759,620 shares, representing 0.24% for CNY 54.71 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39 CNY | +6.21% |
|
+3.45% | -3.75% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.75% | 1.6B | |
+5.16% | 212B | |
+9.62% | 188B | |
+31.18% | 157B | |
+33.37% | 114B | |
+3.46% | 64.01B | |
+1.51% | 48.83B | |
-4.27% | 39.3B | |
+0.88% | 35.97B | |
+8.44% | 27B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.